Cost and effectiveness of non-penetrating deep sclerectomy ...
Cost and effectiveness of non-penetrating deep sclerectomy ...
Cost and effectiveness of non-penetrating deep sclerectomy ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ÍNDICE - V. 74 - 2011<br />
Purpura, Schoenlein-Henoch, 368<br />
Quality control, 17<br />
Quality <strong>of</strong> life, 410<br />
Questionnaires, 323, 452<br />
Q<br />
R<br />
Rabbits, 352<br />
R<strong>and</strong>omized controlled trial, 417<br />
Reconstructive surgical procedures, 444<br />
Recovery <strong>of</strong> function 330<br />
Refractive errors, 166<br />
Refractive surgical procedures, 102<br />
Renal dialysis, 106<br />
Renal insufficiency, chronic, 106<br />
Reoperation, 171<br />
Retina, 37, 190, 306, 335, 352<br />
blood supply, 395<br />
physiopathology, 222<br />
Retinal detachment, 143, 292, 335<br />
Retinal diseases, 190, 449<br />
drug therapy, 352<br />
Retinal hemorrhage, 368<br />
Retinal pigment epithelium, 449<br />
Retinal pigments, 289<br />
Retinal vasculitis, 368<br />
Retinal vein occlusion<br />
chemically induced, 214<br />
Retinal vessels, 190<br />
Retinoblastoma, 365<br />
Retinochoroiditis, 255<br />
Retinoids<br />
therapeutic use, 55<br />
Retinopathy <strong>of</strong> prematurity, 217, 279<br />
therapy, 251<br />
Rheumatic diseases, 405<br />
Rheumatoid arthritis<br />
drug therapy, 214<br />
Rib<strong>of</strong>lavin, 67<br />
pharmacokinetics, 348<br />
Risk factors, 7, 217, 251<br />
S<br />
Salivary gl<strong>and</strong>s<br />
transplantation, 425<br />
Sclera<br />
injuries, 134<br />
pathology, 53, 430<br />
surgery, 201<br />
Scleritis, 132, 405<br />
Sclerostomy, 201<br />
Sebaceous adenocarcinoma, 444<br />
Sebaceous gl<strong>and</strong> neoplasms<br />
diagnosis, 444<br />
Severity <strong>of</strong> illness index, 414<br />
Sickle cell disease, 335<br />
Signs <strong>and</strong> symptoms, 255<br />
Sleep apnea, obstructive<br />
complications, 64<br />
Social adjustment, 330<br />
Socioeconomic factors, 33<br />
Stem cells, 114, 248<br />
Strabismus, 24<br />
etiology, 211<br />
surgery, 24, 180<br />
Survival rates, 251<br />
Sutures, 123<br />
Swine, 348<br />
Syndrome, 64<br />
T<br />
Tissue <strong>and</strong> organ procurement, 17<br />
Tissue donors, 17<br />
Tissue preservation, 17<br />
Tomography, optical coherence, 289, 338, 343, 371, 395<br />
Tomography, x-ray, 58<br />
Tonometry, ocular, 102, 161<br />
Toxoplasmosis, congenital, 255<br />
Trabeculectomy, 300<br />
methods, 201<br />
Transplantation, autologous, 184, 248<br />
Treatment outcome, 357, 425<br />
Treatment, tear trough, 44<br />
Triamcinolone<br />
therapeutic use, 343<br />
Tuberculoma, 53<br />
Tuberculosis, ocular<br />
diagnosis, 53<br />
immunology, 53<br />
Tumor necrosis factor-alpha, 352<br />
U<br />
Ultrasonography, Doppler, color<br />
methods, 361<br />
Ultraviolet rays, 348<br />
Ultraviolet therapy, 67<br />
Uveitis, 395<br />
diagnosis, 258<br />
microbiology, 258<br />
virology, 258<br />
Uveitis, anterior<br />
drug therapy, 132<br />
V<br />
Validation studies, 262<br />
Vasculitis, 368<br />
Vision disorders, 175<br />
diagnosis, 222<br />
Vision tests, 91<br />
Vision, binocular, 171<br />
physiology, 184<br />
Vision, ocular, 33<br />
Visual acuity, 91, 127, 184, 410, 430, 449<br />
Visual fields, 88<br />
Visual pathways<br />
pathology, 222<br />
Visual perception, 91<br />
Vitrectomy, 143, 296<br />
Vitreoretinopathy, proliferative, 292<br />
Vitreous body, 258, 338<br />
Vitreous hemorrhage, 143, 335<br />
Xerophthalmia, 425<br />
X<br />
W<br />
Waardenburg´s syndrome, 209<br />
Wounds, gunshot<br />
complications, 58<br />
470 Arq Bras Oftalmol. 2011;74(6):463-74
Change language